{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:37:53Z","timestamp":1782801473556,"version":"3.54.5"},"reference-count":13,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,7]]},"DOI":"10.1182\/blood-2017-12-822940","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T19:58:21Z","timestamp":1524081501000},"page":"2596-2598","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy"],"prefix":"10.1182","volume":"131","author":[{"given":"Theodore W.","family":"Laetsch","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX;"},{"name":"Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Maude","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Milone","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies,"},{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Krueger","sequence":"additional","affiliation":[{"name":"Division of Haematology\/Oncology\/BMT, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Cardenas","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Infectious Disease Diagnostics Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamis K.","family":"Eldjerou","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Keir","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Wood","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Grupp","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111904103929500_B1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMoa1504542","article-title":"Chimeric antigen receptor T cells against CD19 for multiple myeloma","volume":"373","author":"Garfall","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"2019111904103929500_B2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111904103929500_B3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111904103929500_B4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo","volume":"17","author":"Milone","year":"2009","journal-title":"Mol Ther"},{"issue":"3","key":"2019111904103929500_B5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BJ20120146","article-title":"Lentiviral vectors: basic to translational","volume":"443","author":"Sakuma","year":"2012","journal-title":"Biochem J"},{"issue":"1","key":"2019111904103929500_B6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2017.10.012","article-title":"Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients","volume":"26","author":"Marcucci","year":"2018","journal-title":"Mol Ther"},{"issue":"1","key":"2019111904103929500_B7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ymthe.2017.09.008","article-title":"Absence of replication-competent lentivirus in the clinic: analysis of infused T cell products","volume":"26","author":"Cornetta","year":"2018","journal-title":"Mol Ther"},{"issue":"2","key":"2019111904103929500_B8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/mt.2013.296","article-title":"False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector","volume":"22","author":"De Ravin","year":"2014","journal-title":"Mol Ther"},{"key":"2019111904103929500_B9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"2019111904103929500_B10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/biol.1999.0226","article-title":"Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools","volume":"27","author":"Yang","year":"1999","journal-title":"Biologicals"},{"issue":"4","key":"2019111904103929500_B11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diagmicrobio.2017.05.016","article-title":"False-positive HIV nucleic acid amplification testing during CAR T-cell therapy","volume":"88","author":"Ariza-Heredia","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"2019111904103929500_B12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJMc051339","article-title":"Common variable immunodeficiency and testing for HIV-1","volume":"353","author":"Padeh","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111904103929500_B13","unstructured":"Complete list of donor screening assays for infectious agents and HIV diagnostic assays. U.S. Food and Drug Administration Website. https:\/\/www.fda.gov\/biologicsbloodvaccines\/bloodbloodproducts\/approvedproducts\/licensedproductsblas\/blooddonorscreening\/infectiousdisease\/ucm080466.htm#anti_HIV1_Assays. Updated 2018. Accessed 23 March 2018."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/23\/2596\/1468255\/blood822940.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/23\/2596\/1468255\/blood822940.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T09:13:59Z","timestamp":1574154839000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/23\/2596\/36940\/Falsepositive-results-with-select-HIV1-NAT-methods"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":13,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,6,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-12-822940","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]}}}